NCT06886204 · Emory University
Youth Participatory Action Research to Prevent Community Violence Among Black Youth
What this study is about
This behavioral intervention study aims to evaluate the effectiveness of Youth Empowered Advocating for Health (YEAH) on youth prosocial behavior and aggressive behavior and assess racial identity and future orientation as mediators of prevention effects.
View original scientific description
This behavioral intervention study aims to evaluate the effectiveness of Youth Empowered Advocating for Health (YEAH) on youth prosocial behavior and aggressive behavior and assess racial identity and future orientation as mediators of prevention effects.
Interventions
BEHAVIORAL
YEAH: Youth Empowered Advocating for Health
The Youth Empowered Advocating for Health (YEAH) program is a Youth Participatory Action Research (YPAR) intervention aimed at addressing community violence by fostering youth and community healing. It combines photovoice and theater arts performances. In photovoice sessions, Black youth explore structural determinants of community violence through a participatory research process. Guided by trained facilitators, youth learn the method after obtaining parental consent and youth assent. Using the structured SHOWED framework, they analyze and discuss images, generating ideas for social action. During the photovoice sessions, photo assignments will be completed, with discussions recorded, analyzed for themes, and shared for validation. The final four sessions will integrate these themes into theater arts performances, allowing youth to creatively express insights and experiences, fostering empowerment and social change.
Primary outcome measures
Change in prosocial behavior: Multidimensional Well-being Assessment Scale
Time frame: Baseline, Week 8, Month 3
Youth prosocial behavior will be measured using a scale developed by Grills et al. (2016) which assesses youth endorsement of behaviors that build connections with others in the past 2 weeks (α=.92). This 12-item scale was developed from items from the Multidimensional Well-being Assessment Scale, and uses a Likert-type scale (1=never; 5=always), with higher mean scores indicating greater likelihood of engaging in behaviors that reflect care and concern for others
Change in aggressive behavior: California Healthy Kids Survey adaptation
Time frame: Baseline, Week 8, Month 3
Youth aggressive behavior will be measured using 10 items adapted from the California Healthy Kids Survey. This measure asks participants how often they engaged in behaviors such as yelling at teachers, hitting or punching someone, or teasing another student in the past month (α=.88). These items assess the frequency of behaviors with 5 response categories (0,1,2,3,4+).
Change in community violence exposure: Community Experiences Questionnaire
Time frame: Baseline, Week 8, Month 3
This will be measured with 14 items (items 12-25) from the Community Experiences Questionnaire assessing exposure to violence by witnessing (CEQ-WIT). This scale asks the respondent to rank the frequency with which they have experienced each item on a 4-point rating scale (1=never, 2=once, 3=a few times, 4=lots of times). Scores are calculated by averaging respondents' ratings for the scale
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Identify their race or ethnicity as Black or African American
- Speak English
- Able to understand the project and give full consent to participate if eligible
- Have a parent or guardian provide consent for them to participate
- Member of Boys and Girls Clubs or other Youth Serving Organization (YEAH immediate intervention and delayed intervention groups)
Exclusion criteria
- Non-English speakers
Where
- Atlanta, Georgia
Collaborators
Centers for Disease Control and Prevention
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Aug 26, 2025 · Source of record for eligibility and locations